A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
Clinical trial NCT02034747 · COMPLETED
Trial details
- NCT number
- NCT02034747
- Sponsor
- Astellas Pharma Korea, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-21
- Primary completion
- 2015-11-07
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.